Sleep Health | Sleep Review
Mind Medicine (MindMed), a biotech company developing psychedelic-inspired therapies, announced that it has started recruiting for a randomized, placebo-controlled study to investigate the effects of repeated administration of low doses of LSD during the day and evening.
Researchers will use digital meters and software to measure the effects of microdoses of LSD on markers of neuroplasticity such as plasma BDNF levels, as well as various sleep measurements, mood, cognitive performance, emotion regulation, quality of life, and immune system response. The study is being conducted by Kim Kuypers, PhD, of Maastricht University, a global authority on the use of low-dose psychedelics.
“Research into the practice of repeated low-dose psychedelics begins with the basics and examines whether there is a time of day that affects the effects of these treatments,” Kuypers said in a press release. “We are investigating whether repeated ingestion of lower doses could lead to a reorientation of thought patterns that would allow individuals to achieve levels of self-awareness that an enriched life experience can provide.”
“The so-called ‘microdosing’ of psychedelics is increasingly being asserted in terms of their potential to influence mental and physical well-being, cognition, memory and certain aspects such as creativity and productivity,” says Miri Halperin Wernli, PhD, MindMed Managing Director President says in a statement.
Photo: ID 156513536 © Bakalaerozz Photography | Dreamstime.com